GlobeNewswire

Cloudian and Storage Made Easy Launch GDPR-Ready Enterprise File Sync-and-Share Solution

Dela

Ensures compliance by controlling user data location and access, while monitoring for use of regulated personal data

LONDON and SAN MATEO, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Cloudian® and Storage Made Easy® (SME) have launched a General Data Protection Regulation (GDPR)-ready, enterprise-wide file sync-and-share solution, designed to eliminate the compliance exposure of external cloud-based file sharing services where personal data or company confidential information may reside outside the direct control of the IT organization.

The combined solution includes on-premises storage and GDPR-ready collaboration software with access controls and content indexing to continuously monitor for the use of regulated personal data, recognising more than 60 data types including credit card, passport and social security numbers.

Unlike most cloud-based file sharing services, the Cloudian/SME solution lets IT managers control their data's physical location and manage access permissions via existing company authentication frameworks such as Active Directory and LDAP. The solution also provides secure file sharing controls such as password-protected links, configurable download limits, and expiration dates after which links will be disabled automatically. All data accesses are logged, maintaining an audit trail for compliance.   

"With GDPR now in effect, organizations must implement tight controls over data location and usage -- particularly when personal data is at stake -- requirements that most cloud-based services do not meet," said Michael Tso, CEO of Cloudian. "The Cloudian/SME solution gives IT managers peace-of-mind, with end-to-end control of data location and access, and a continuous view of where files are stored, how they are shared, and where personal data is employed."

Compatible with Windows, Mac, Linux, iOS and Android platforms, the solution includes configurable synchronization options that let users control where data is replicated, and integration with Microsoft Office and email applications that allow users to securely access and share files.

"Users are going to share information, but that does not mean that IT managers need to lose control. The challenge is to provide easy-to-use file sharing that boosts productivity while ensuring that sensitive information remains secure," said Jim Liddle, CEO of Storage Made Easy. "Cloudian and SME together provide the best of both worlds, combining the simplicity of a cloud-like solution, the security of on-premises storage, and the comprehensive compliance enforcement afforded by our GDPR-ready feature set."

Multiple privacy regulations mandate strict controls on data handling, including the EU General Data Protection Regulation and the California Consumer Privacy Act of 2018. These require that companies collecting personal data - which includes a wide range of information such as names, identification numbers, location data or online identifiers - both protect the data and delete it if requested. Compliance requires tight controls on how such information is stored and used.

"Our customers needed a turnkey solution to simplify compliance, and we responded with CloudDrive, a Cloudian and Storage Made Easy-based solution that provides GDPR-aligned file sync-and-share service for the enterprise," said Julian Box, CEO at Calligo. "With Cloudian storage and SME software, our customers get easy-to-use file sharing and powerful data management tools that keep IT in control, making compliance one less thing to worry about."

About Store Made Easy
Storage Made Easy provides a multi-cloud data management and data protection product called the Enterprise File Fabric(TM) that unifies on-premises and on-cloud company storage assets, in addition to standalone products that bridge desktop and cloud, such as operating system-native cloud drives and cloud explorer applications. The company is backed by one of the largest alternative asset managers in addition to entrepreneurs in the London market insurance industry, who have previously successfully sold their company to a listed peer.

Storage Made Easy is the trading name of Vehera LTD. Follow us on Twitter @SMEStorage and visit us at www.StorageMadeEasy.com to learn more.

About Cloudian
Cloudian turns information into insight with an infinitely scalable platform that consolidates, manages and protects enterprise data. Cloudian data management solutions bring cloud technology and economics to the data centre with uncompromising data durability, intuitive management tools, and the industry's most compatible S3 API. Cloudian and its ecosystem partners help Global 1000 customers simplify unstructured data management today, while preparing for the data demands of AI and machine learning tomorrow.

Join us on LinkedIn, follow us on Twitter (@CloudianStorage) and Facebook, or visit us at www.cloudian.com.

Media Contacts

Emily Gallagher
Touchdown PR 
Cloudian@touchdownpr.com
+44 (0)1252 717040

Alex Mercurio
10Fold Communications 
cloudian@10fold.com 
949-940-5656




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cloudian via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum